Cynbiose is a Contract Research Organization (CRO) that is AAALAC accredited. The company specializes in the development and commercialization of innovative non-human primate models to accelerate the preclinical development phases of drug candidates. It works on exploratory pharmacokinetics and toxicology studies, as well as proof-of-concept studies in different human pathologies, such as infectious diseases and respiratory conditions, the central nervous system and inflammatory and musculoskeletal disorders and cardiovascular/neurovascular diseases.